Treatment-shortening effect of a novel regimen combining high-dose rifapentine and clofazimine in pathologically distinct mouse models of tuberculosis

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Epidemiology

Medicine

Immunology

Microbiology

Show all topics

DOI

10.1101/556654

License

CC-BY-NC-ND

Other Formats

PDF